• Users Online: 5017
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
INVITED DRUG REVIEW
Year : 2022  |  Volume : 24  |  Issue : 1  |  Page : 1-7

Isavuconazole - The new triazole


Department of Microbiology, St. John's Medical College and Hospital, St. John's National Academy of Health Sciences, Bengaluru, Karnataka, India

Correspondence Address:
Dr. Jayanthi Savio
Department of Microbiology, St. John's Medical College and Hospital, St. John's National Academy of Health Sciences, Sarjapur Road, Bengaluru - 560 034, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jacm.jacm_11_22

Rights and Permissions

The increase in susceptible population to invasive fungal infections, especially candidemia and aspergillosis has resulted in the introduction of newer antifungal agents, especially in the azole group. Isavuconazole is one such agent with an extended antifungal spectrum. It is found to be useful not only in the management of candidemia and aspergillosis but also mucormycosis.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed504    
    Printed20    
    Emailed0    
    PDF Downloaded9    
    Comments [Add]    

Recommend this journal